For Patients

Cancer Treatment Updates

Study of “exceptional responders” yields clues to cancer and potential treatments

November 19th, 2020

A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.

Read More

NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19

September 15th, 2020

NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.

Read More

NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research

August 27th, 2020

NCI and Cancer Research UK will partner to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research.

Read More

New treatments spur sharp reduction in lung cancer mortality rate

August 12th, 2020

Mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment, an NCI study shows.

Read More

AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study

June 25th, 2020

In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.

Read More

NIH scientists develop blood test to help improve liver cancer screening

June 11th, 2020

The new test is relatively simple and could improve screening for people who are at risk for developing hepatocellular carcinoma (HCC), the most common form of liver cancer. It could help doctors find and treat HCC early.

Read More

Study identifies potential approach to treat severe respiratory distress in patients with COVID-19

June 5th, 2020

As described in an NCI Media Availability, early data from a clinical study suggest that treatment with the cancer drug acalabrutinib provided clinical benefit to a small group of patients with severe COVID-19.

Read More

Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma

May 26th, 2020

In an NCI study, an alternative treatment regimen called dose-adjusted EPOCH-R that is less toxic than standard dose-intensive chemotherapy was highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.

Read More

Higher daily step count linked with lower all-cause mortality

March 24th, 2020

In a new study, higher daily step counts were associated with lower mortality risk from all causes. Researchers found that the number of steps taken each day, but not the intensity of the stepping, had a strong association with mortality.

Read More

NCI statement on clinical trials during COVID-19 pandemic

March 19th, 2020

Statement from the National Cancer Institute providing information regarding treatment of cancer patients and participation in clinical trials during the COVID-19 pandemic.

Read More

 1 2 3 >  Last ›